13.02.2024 - WOBURN, Mass., Feb. 13, 2024 (GLOBE NEWSWIRE) - NeuroMetrix, Inc. (Nasdaq: NURO), a commercial stage medical device company focused on reducing the impact of neurological disorders and pain syndromes through innovative non-invasive medical ...